Italian Sarcoma Group

Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups

Alessandro Gronchi, Emanuela Palmerini, Vittorio Quagliuolo et al. · Journal of Clinical Oncology · 2020 · 261 citations · Full text

Medicine, Oncology, Pharmacology +17

Neoadjuvant chemotherapy in high‐risk soft tissue sarcomas: A Sarculator‐based risk stratification analysis of the ISG‐STS 1001 randomized trial

Sandro Pasquali, Emanuela Palmerini, Vittorio Quagliuolo et al. · Cancer · 2021 · 101 citations · Full text

Medicine, Oncology, Surgery +16

Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group

Giovanni Grignani, Lorenzo D’Ambrosio, Ymera Pignochino et al. · The Lancet Oncology · 2018 · 95 citations · Full text

Medicine, Oncology, Surgery +13

Parosteal osteosarcoma: a monocentric retrospective analysis of 195 patients

Poosit Ruengwanichayakun, Marco Gambarotti, Tommaso Frisoni et al. · Human Pathology · 2019 · 38 citations

Medicine, Oncology, Surgery +14

Phase 2 study for nonmetastatic extremity high‐grade osteosarcoma in pediatric and adolescent and young adult patients with a risk‐adapted strategy based on ABCB1/P‐glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS‐2)

Emanuela Palmerini, Cristina Meazza, Angela Tamburini et al. · Cancer · 2022 · 35 citations · Full text

Medicine, Oncology, Pharmacology +17